91ÁÔÆæ

Faculty Profile

Tiansheng WangTiansheng Wang

Assistant Professor, 
Department of Pharmaceutical Health Outcomes and Policy

Office: 
91ÁÔÆæ College of Pharmacy
Health 2, Room 4051
4349 Martin Luther King Boulevard
Houston, TX 77204-5047

Contact: tianwang@uh.edu - 713-743-2319

Website:

Research:

Dr. Wang's research focuses on developing and applying AI- and machine learning–powered causal inference methods to learn what works (or harms) from real-world data, with an emphasis on precision medicine, confounding control, and leveraging multimodal data (genetic, imaging, and real-world claims) to assess drug effects. He has eight years of experience analyzing health data, including claims, electronic health records, and registries.

  • Post-doctoral Scholar, Department of Epidemiology, University of North Carolina, Chapel Hill, NC
  • Ph.D. in Epidemiology, University of North Carolina, Chapel Hill, NC
  • Pharm.D., North Dakota State University, Fargo, ND
  • Master of Science in Pharmaceutical Sciences, North Dakota State University, Fargo, ND
  • Bachelor of Science in Pharmaceutical Sciences, Shenyang Pharmaceutical University, China

Key publications:

  • Wang T, Keil AP, Kim S, Wyss R, Htoo PT, Funk MJ, Buse JB, Kosorok MR, Stürmer T. Iterative Causal Forest: A Novel Algorithm for Subgroup Identification. Am J Epidemiol. 2024;193(5):764–776.
  • Wang T, Pate V, Wyss R, Buse JB, Kosorok MR, Stürmer T. High-dimensional Iterative Causal Forest (hdiCF): a Novel Algorithm for Subgroup Identification in Claims Data. Am J Epidemiol. 2024;194(7):2085–97.
  • Wang T, Wang J, Song Z, Miller E, Pate V, Her Q, Yang J, Charlier SHR, Egger P, Barnes EL, Buse JB, Becker C, Sandler RS, Meier C, Jick S, Stürmer T. Caution in Handling Switchers in Pharmacoepidemiologic Studies Estimating Treatment Effects: The Example of Dipeptidyl Peptidase-4 Inhibitors and Inflammatory Bowel Disease. Am J Epidemiol. 2025. https://doi.org/10.1093/aje/kwaf044
  • Wang T, Yang YJ, Buse JB, Pate V, Tang H, Barnes EL, Sandler RS, Stürmer T. Dipeptidyl Peptidase-4 Inhibitors and Risk of Inflammatory Bowel Disease: Real-World Evidence in US Adults. Diabetes Care. 2019;42(11):2065–2074.
  • Wang T, Pate V, Kim DH, Power MC; Garden G, Palta P, Knopman D, Jonsson-Funk M, Stürmer T, Kucharska-Newton AM. Developing a Novel Algorithm to Identify Incident and Prevalent Dementia in Medicare Claims for Pharmacoepidemiologic Studies: The ARIC Study. Am J Epidemiol. 2025; kwaf166. https://doi.org/10.1093/aje/kwaf166

 

  • 2022 Editorial Consultant, American Journal of Epidemiology
  • 2021 Editorial Consultant, American Journal of Epidemiology
  • 2020 The Merck-Guess Scholarship in Pharmacoepidemiology, Chapel Hill, NC
  • 2018 The 13th Science and Technology Award of Chinese Pharmaceutical Association, Beijing, China
  • 2017 The 12th Science and Technology Award of Chinese Pharmaceutical Association, Beijing, China
  • 2015 Outstanding Young Faculty Award, Peking University, Beijing, China
  • 2010 Rx Increase Achievement Award, Rite Aid, Covington, WA